IP Library › Granted Patent US 11,946,838
Granted Patent B2
US 11,946,838 · App. 17/374,859 · Granted Apr 2, 2024

Calibration slides for digital pathology

Inventor: Christian Roessler (Oro Valley, AZ)
Assignee: Ventana Medical Systems, Inc.
G01N1/28C08J3/075C08J2205/022C08J2333/06G01N2001/2893
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,946,838
App. No.
17/374,859
Granted
Apr 2, 2024
Kind
B2
Abstract

In some embodiments, the present disclosure is directed to coatings or thin films comprising a dye or stain embedded within a matrix, e.g. a polymer matrix.

Claims (31)

1. A calibration system comprising:

(a) an optically transparent substrate;

(b) a film having a substantially uniform thickness disposed on at least a portion of the optically transparent substrate, the film comprising a chromogenic precipitate embedded within a polymer, wherein the chromogenic precipitate is uniformly dispersed within the polymer.

2. The calibration system of claim 1 , wherein the polymer is a hydrogel.

3. The calibration system of claim 2 , wherein the hydrogel comprises crosslinked gelatin.

4. The calibration system of claim 3 , wherein the crosslinked gelatin is derived from gelatin and an aldehyde.

5. The calibration system of claim 2 , wherein the hydrogel is derived from a gelling agent and a crosslinking agent.

6. The calibration system of claim 1 , wherein the polymer is an acrylate.

7. The calibration system of claim 1 , wherein the chromogenic precipitate is a reaction product of a chromogen and an enzyme.

8. The calibration system of claim 7 , wherein the chromogen is selected from the group consisting of 5-Bromo-4-Chloro-3-Indolyl Phosphate; 4-Chloro-2-methyl benzenediazonium; 3,3′-Diaminobenzidine; 3,3′,5,5;-tetramethylbenzidine; 4-chloro-1-naphthol; 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); o-phenylenediamine dihydrochloride; p-Nitrophenyl Phosphate; 5-Bromo-4-Chloro-3-indolyl-B-D-Galactopyranoside; and 2,2,5-5-tetra-p-nitrophenyl-3,3-(3,3-dimethoxy-4,4-biphenylene)-di tetrazolium chloride.

9. The calibration system of claim 8 , wherein the chromogen is 3,3′-Diaminobenzidine.

10. The calibration system of claim 8 , wherein the enzyme is selected from the group consisting of alkaline phosphatase, horseradish peroxidase, glycosylases, and glucose oxidase.

11. The calibration system of claim 1 , wherein a ratio of the chromogenic precipitate to the polymer ranges from about 0.1 to about 50.

12. A set of slides comprising:

(a) a first slide having a first coating disposed on at least a portion of an upper surface of the first slide, the first coating comprising a stain present in a polymeric matrix at a first concentration;

(b) a second slide having a second coating disposed on at least a portion of an upper surface of the second slide, the second coating comprising the stain present in the polymeric matrix at a second concentration;

wherein the first concentration and the second concentration are different.

13. The set of slides of claim 12 , wherein the stain is a chromogenic precipitate.

14. The set of slides of claim 13 , wherein the chromogenic precipitate is derived from one of 5-Bromo-4-Chloro-3-Indolyl Phosphate; 4-Chloro-2-methyl benzenediazonium; 3,3′-Diaminobenzidine; 3,3′,5,5;-tetramethylbenzidine; 4-chloro-1-naphthol; 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); o-phenylenediamine dihydrochloride; p-Nitrophenyl Phosphate; 5-Bromo-4-Chloro-3-indolyl-B-D-Galactopyranoside; or 2,2,5-5-tetra-p-nitrophenyl-3,3-(3,3-dim ethoxy-4,4-biphenylene)-di tetrazolium chloride.

15. The set of slides of claim 12 , wherein the second concentration is at least twice the first concentration.

16. A kit comprising:

(i) a first set of coating reagents comprising:

a. a first intermediate coating solution comprising a first matrix forming component and an enzyme; and

b. a second intermediate coating solution comprising a chromogen, wherein the chromogen is present in the second intermediate coating solution at a first concentration; and

(ii) a second set of coating reagents comprising

a. a third intermediate coating solution comprising the first matrix forming component and the enzyme; and

b. a fourth intermediate coating solution comprising the chromogen, wherein the chromogen is present in the fourth intermediate coating solution at a second concentration.

17. The kit of claim 16 , further comprising a fifth intermediate coating solution comprising a crosslinking reagent.

18. The kit of claim 16 , wherein the chromogen is selected from the group consisting of 5-Bromo-4-Chloro-3-Indolyl Phosphate; 4-Chloro-2-methyl benzenediazonium; 3,3′-Diaminobenzidine; 3,3′,5,5;-tetramethylbenzidine; 4-chloro-1-naphthol; 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); o-phenylenediamine dihydrochloride; p-Nitrophenyl Phosphate; 5-Bromo-4-Chloro-3-indolyl-B-D-Galactopyranoside; and 2,2,5-5-tetra-p-nitrophenyl-3,3-(3,3-dimethoxy-4,4-biphenylene)-di tetrazolium chloride.

19. The kit of claim 16 , wherein the chromogen is 3,3′-Diaminobenzidine.

20. The kit of claim 18 , wherein the enzyme is selected from the group consisting of alkaline phosphatase, horseradish peroxidase, glycosylases, and glucose oxidase.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: ROESSLER, CHRISTIAN
To: VENTANA MEDICAL SYSTEMS, INC.
Reel/Frame 056843/0648 →
Continuity (3)
Continuation PCTEP2020051848 · Jan 27, 2020
Provisional Application 62798595 · Jan 30, 2019
Related Publication 20220003639A1 · Jan 6, 2022
Cited By (1)
US 12,298,207